Morgan Stanley’s Macro Strategy Assessment – EGYPT
Part 1: Morgan Stanley’s Macro Strategy Assessment
Morgan Stanley’s latest assessment is more constructive on Egypt than its earlier outlook. The central message is that Egypt has demonstrated greater resilience to the regional geopolitical shock than initially expected.
1. External Position is Stronger Than Expected
- Strong remittance inflows, exchange-rate flexibility, and improving FDI prospects are reducing Egypt’s external financing vulnerability.
- The major remaining risk is a sharp reversal of foreign portfolio flows.
2. Remittances as a Structural Source of FX Liquidity
Morgan Stanley attributes this sustained increase to the increased formalization of remittance flows, a larger overseas Egyptian workforce, and a more flexible foreign exchange regime.
3. Oil and Monetary Policy Outlook
- Oil Risks: Oil remains the principal external risk, though scheduled multilateral financing would substantially reduce financing gaps.
- Inflation: Forecast reduced to approximately 11.8% for December 2026, with a projected peak of around 15.2% in Q3 2026.
- Interest Rates: The Central Bank of Egypt (CBE) is expected to remain on hold through year-end, with an increased probability of a rate cut in Q4 2026 if geopolitical conditions improve.
4. FX Framework & FDI Prospects
The flexible exchange-rate regime serves as a crucial shock absorber, preventing the need to defend an artificial level. Furthermore, net FDI is projected at US$13–15 billion in FY27, supported by energy-investment pipelines and the government’s asset-sale program.
Part 2: Tashawer Opinion — Strategic Impact on Healthcare
1. Expanding the Investment Scope
Improved external financing conditions and FX stability create a stronger environment for long-term capital deployment across key sectors:
- Hospitals & Medical Cities
- Diagnostic Networks & Specialized Centers
- Healthcare Platforms & Digital Health
- Health Insurance & TPA Businesses
- Medical Tourism & Healthcare M&A
2. Managing FX Sensitivity and Cost Inflation
Healthcare remains exceptionally sensitive to FX due to supply chain reliance on foreign currency for medical equipment, pharmaceuticals, implants, consumables, laboratory technology, and IT infrastructure. FX stability is therefore more critical to healthcare than headline GDP growth.
Even with inflation dropping toward 12%, providers will face cost pressures across labor, utilities, and inputs. Future performance must be driven by operational execution rather than simple price increases:
3. Rate Cuts and Healthcare M&A Acceleration
Anticipated CBE interest rate cuts in Q4 2026 could lower financing costs for hospital construction, equipment acquisitions, and working capital, accelerating private equity transactions and market consolidation.




